Abstract
Acute hepatic failure caused by primary Epstein-Barr virus (EBV) infection has been reported in the literature in 16 cases, with an overall mortality of 87%. We report a case of fulminant hepatic failure in an immunocompetent young girl caused by primary EBV infection that was treated by orthotopic liver transplantation. After transplantation she has been treated with low-dose immuno-suppression, a pooled gammaglobulin preparation containing anti-EBV antibodies, and anti-viral therapy. The patient is presently doing well 2 years after transplantation without evidence of clinical EBV infection, primary immunodeficiency, or lymphoproliferative disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 469-476 |
| Number of pages | 8 |
| Journal | Liver Transplantation and Surgery |
| Volume | 4 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1998 |
ASJC Scopus subject areas
- Surgery
- Hepatology